The Hoggatt Laboratory is a stem cell and regenerative biology research group at Harvard Medical School / Massachusetts General Hospital and is affiliated with both the MGH Cancer Center and Center for Transplantation Sciences as well as the Harvard Stem Cell Institute. We are broadly interested in tissue regeneration and stem cell biology, with a particular focus on translational research to enhance bone marrow transplantation.

Research efforts over the last several decades working to develop therapies have largely focused on finding “magic bullets”, a small molecule or perhaps protein biologic that can be given to the patient as a drug to cure their disease. We believe that the cures of the future will come from tapping in to the body’s natural regenerative capacities or will use cellular therapies, namely stem cell transplantation. Our goals are to discover new regenerative pathways within the body to allow for disease correction and to make stem cell transplantation faster, safer, cheaper and better to broaden its use to more patients.